Is Etanercept 25mg once weekly as effective as 50mg at maintaining response in patients with ankylosing spondylitis? A randomized control trial

Yates, Max, Hamilton, Louise E., Elender, Frances, Dean, Loretta, Doll, Helen, MacGregor, Alex J. ORCID: https://orcid.org/0000-0003-2163-2325, Thomas, Joegi and Gaffney, Karl (2015) Is Etanercept 25mg once weekly as effective as 50mg at maintaining response in patients with ankylosing spondylitis? A randomized control trial. Journal of Rheumatology, 42 (7). pp. 1177-1185. ISSN 0315-162X

Microsoft Word (FinalAnswersClean 10th Mar2015) - Accepted Version Download (73kB)

Abstract

To investigate, in a pilot randomized controlled trial, whether etanercept (ETN) 25 mg once weekly is effective at maintaining a clinical response in patients with ankylosing spondylitis (AS) who have responded to the standard 50 mg dose.

Item Type:	Article
Uncontrolled Keywords:	ankylosing spondylitis,anti-tumor necrosis factor therapy,etanercept,randomized control trial
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School Faculty of Medicine and Health Sciences > Allied Health Professions
Depositing User:	Pure Connector
Date Deposited:	19 Aug 2015 15:16
Last Modified:	21 Oct 2022 01:05
URI:	https://ueaeprints.uea.ac.uk/id/eprint/54126
DOI:	10.3899/jrheum.141335

Actions (login required)

View Item